Special Issue

Topic: Hypogonadism in Cardiometabolic Disorders

A Special Issue of Metabolism and Target Organ Damage

ISSN 2769-6375 (Online)

Submission deadline: 31 May 2024

Guest Editor(s)

Daniele Santi, MD, PhD

Unit of Endocrinology, Department of Medical Specialties, Azienda Ospedaliero-Universitaria of Modena, Ospedale Civile of Baggiovara, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy.

Angelo Cignarelli, MD, PhD

Department of Emergency and Organ Transplantation, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Italy.

Special Issue Introduction

Hypogonadism identifies a clinical condition characterized by the impairment of gonadal function in both sexes, generally due to a partial or total breakdown of the cross-communication between and/or within the hypothalamus, pituitary and gonads. Hypogonadism is largely suspected to be related to several systemic diseases. Whether the systemic illnesses cause real hypogonadism or whether the find of gonadal dysfunction represents an epiphenomenon of the primary systemic disease remains far to be completely elucidated.

This Special Issue is designed to highlight the relationship between the most common chronic systemic diseases and hypogonadism in both males and females. Following topics will be discussed in this issue:
● Hypogonadism in NAFLD
● Hypogonadism in chronic kidney disease
● Hypogonadism in chronic hypoxia
● Hypogonadism in iron overload disease
● Hypogonadism in diabetes mellitus
● Hypogonadism in overweight and obesity
● Hypogonadism in cardiovascular diseases
etc.